We Need a Vaccine: Proposals for Regulating Innovation in a Pandemic   [open pdf - 0B]

From the Introduction: "As of mid-January 2021, two COVID-19 [coronavirus disease 2019] vaccines had been approved (Pfizer-BioNtech and Moderna) for widespread use in the United States and another three are in large-scale, Phase 3 clinical trials (AstraZeneca, Janssen, and Novavax). [...] Against this backdrop of breathtaking invention and innovation in the fight against the COVID-19 virus is another story - that of the war on intellectual property. Although this battle is not new, the pandemic has provided additional narratives of entry. Ranging from calls for innovators to either 'voluntarily' forgo obtaining or exercising their legal patent rights on COVID-19 technology to calls for governments to simply take the rights to these patented inventions without permission, it is clear that intellectual property is under attack. Because these calls are coming from powerful groups such as Doctors Without Borders (Medecins Sans Frontieres/MSF) to the World Intellectual Property Organization (WIPO) to a novel organization known as the Open COVID Pledge, a group now stewarded by Creative Commons and naming IBM [International Business Machines], Amazon, and Microsoft among its founding pledgors, it is difficult to not feel pushback against innovators' legally-obtained rights."

Report Number:
CSAS Working Paper 21-18; Center for the Study of the Administrative State Working Paper 21-18
George Mason University
Retrieved From:
Center for the Study of the Administrative State: https://administrativestate.gmu.edu/
Media Type:
Help with citations